Global Radiopharmaceuticals in Nuclear Medicine Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
- Report Code : MAI1884432
- Published On: Jul, 2020
- Category : Chemicals & Materials
- Pages : 128
-
Nuclear medicine : Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. A Radiopharmaceutical is a drug that can be used either for diagnostic or therapeutic purposes.
The Radiopharmaceuticals in Nuclear Medicine market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.
Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.
In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Radiopharmaceuticals in Nuclear Medicine industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.
The Radiopharmaceuticals in Nuclear Medicine market can be split based on product types, major applications, and important countries as follows:
Key players in the global Radiopharmaceuticals in Nuclear Medicine market covered in Chapter 12:
Siemens AG
Medtronic, Inc.
Lantheus Medical Imaging
IBA Group
Novartis International AG (Advanced accelerator)
Jubilant Life science
General Electric Co. (healthcare division)
Fujifilm Holding Corporation
Cardinal Health
Curium Pharma
Bayer AG
Lantheus Medical Imaging, Inc.
Mallinckrodt plc
Cardinal Health, Inc.
In Chapter 4 and 14.1, on the basis of types, the Radiopharmaceuticals in Nuclear Medicine market from 2015 to 2025 is primarily split into:
Diagnostic
Therapeutic
In Chapter 5 and 14.2, on the basis of applications, the Radiopharmaceuticals in Nuclear Medicine market from 2015 to 2025 covers:
Oncology
Cardiology
Neurology
Thyroid
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
-
With tables and figures helping analyze worldwide Global Radiopharmaceuticals in Nuclear Medicine market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Table of Content
1 Radiopharmaceuticals in Nuclear Medicine Introduction and Market Overview1.1 Objectives of the Study
1.2 Overview of Radiopharmaceuticals in Nuclear Medicine
1.3 Scope of The Study
1.3.1 Key Market Segments
1.3.2 Players Covered
1.3.3 COVID-19's impact on the Radiopharmaceuticals in Nuclear Medicine industry1.4 Methodology of The Study
1.5 Research Data Source
2 Executive Summary2.1 Market Overview
2.1.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size, 2015 – 2020
2.1.2 Global Radiopharmaceuticals in Nuclear Medicine Market Size by Type, 2015 – 2020
2.1.3 Global Radiopharmaceuticals in Nuclear Medicine Market Size by Application, 2015 – 2020
2.1.4 Global Radiopharmaceuticals in Nuclear Medicine Market Size by Region, 2015 - 20252.2 Business Environment Analysis
2.2.1 Global COVID-19 Status and Economic Overview
2.2.2 Influence of COVID-19 Outbreak on Radiopharmaceuticals in Nuclear Medicine Industry Development
3 Industry Chain Analysis3.1 Upstream Raw Material Suppliers of Radiopharmaceuticals in Nuclear Medicine Analysis
3.2 Major Players of Radiopharmaceuticals in Nuclear Medicine
3.3 Radiopharmaceuticals in Nuclear Medicine Manufacturing Cost Structure Analysis
3.3.1 Production Process Analysis
3.3.2 Manufacturing Cost Structure of Radiopharmaceuticals in Nuclear Medicine
3.3.3 Labor Cost of Radiopharmaceuticals in Nuclear Medicine3.4 Market Distributors of Radiopharmaceuticals in Nuclear Medicine
3.5 Major Downstream Buyers of Radiopharmaceuticals in Nuclear Medicine Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally
4 Global Radiopharmaceuticals in Nuclear Medicine Market, by Type4.1 Global Radiopharmaceuticals in Nuclear Medicine Value and Market Share by Type (2015-2020)
4.2 Global Radiopharmaceuticals in Nuclear Medicine Production and Market Share by Type (2015-2020)
4.3 Global Radiopharmaceuticals in Nuclear Medicine Value and Growth Rate by Type (2015-2020)
4.3.1 Global Radiopharmaceuticals in Nuclear Medicine Value and Growth Rate of Diagnostic
4.3.2 Global Radiopharmaceuticals in Nuclear Medicine Value and Growth Rate of Therapeutic4.4 Global Radiopharmaceuticals in Nuclear Medicine Price Analysis by Type (2015-2020)
5 Radiopharmaceuticals in Nuclear Medicine Market, by Application5.1 Downstream Market Overview
5.2 Global Radiopharmaceuticals in Nuclear Medicine Consumption and Market Share by Application (2015-2020)
5.3 Global Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate by Application (2015-2020)
5.3.1 Global Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate of Oncology (2015-2020)
5.3.2 Global Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate of Cardiology (2015-2020)
5.3.3 Global Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate of Neurology (2015-2020)
5.3.4 Global Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate of Thyroid (2015-2020)
5.3.5 Global Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate of Others (2015-2020)
6 Global Radiopharmaceuticals in Nuclear Medicine Market Analysis by Regions6.1 Global Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Market Share by Regions
6.1.1 Global Radiopharmaceuticals in Nuclear Medicine Sales by Regions (2015-2020)
6.1.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Regions (2015-2020)6.2 North America Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2015-2020)
6.3 Europe Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2015-2020)
6.6 South America Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2015-2020)
7 North America Radiopharmaceuticals in Nuclear Medicine Market Analysis by Countries7.1 The Influence of COVID-19 on North America Market
7.2 North America Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Market Share by Countries
7.2.1 North America Radiopharmaceuticals in Nuclear Medicine Sales by Countries (2015-2020)
7.2.2 North America Radiopharmaceuticals in Nuclear Medicine Revenue by Countries (2015-2020)7.3 United States Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2015-2020)
7.4 Canada Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2015-2020)
7.5 Mexico Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2015-2020)
8 Europe Radiopharmaceuticals in Nuclear Medicine Market Analysis by Countries8.1 The Influence of COVID-19 on Europe Market
8.2 Europe Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Market Share by Countries
8.2.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales by Countries (2015-2020)
8.2.2 Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Countries (2015-2020)8.3 Germany Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2015-2020)
8.4 UK Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2015-2020)
8.5 France Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2015-2020)
8.6 Italy Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2015-2020)
8.7 Spain Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2015-2020)
8.8 Russia Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2015-2020)
9 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Market Analysis by Countries9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Market Share by Countries
9.2.1 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Countries (2015-2020)
9.2.2 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue by Countries (2015-2020)9.3 China Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2015-2020)
9.4 Japan Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2015-2020)
9.5 South Korea Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2015-2020)
9.6 India Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2015-2020)
9.7 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2015-2020)
9.8 Australia Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2015-2020)
10 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Analysis by Countries10.1 The Influence of COVID-19 on Middle East and Africa Market
10.2 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Market Share by Countries
10.2.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Countries (2015-2020)
10.2.2 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue by Countries (2015-2020)10.3 Saudi Arabia Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2015-2020)
10.4 UAE Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2015-2020)
10.5 Egypt Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2015-2020)
10.6 Nigeria Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2015-2020)
10.7 South Africa Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2015-2020)
11 South America Radiopharmaceuticals in Nuclear Medicine Market Analysis by Countries11.1 The Influence of COVID-19 on Middle East and Africa Market
11.2 South America Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Market Share by Countries
11.2.1 South America Radiopharmaceuticals in Nuclear Medicine Sales by Countries (2015-2020)
11.2.2 South America Radiopharmaceuticals in Nuclear Medicine Revenue by Countries (2015-2020)11.3 Brazil Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2015-2020)
11.4 Argentina Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2015-2020)
11.5 Columbia Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2015-2020)
11.6 Chile Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2015-2020)
12 Competitive Landscape12.1 Siemens AG
12.1.1 Siemens AG Basic Information
12.1.2 Radiopharmaceuticals in Nuclear Medicine Product Introduction
12.1.3 Siemens AG Production, Value, Price, Gross Margin 2015-202012.2 Medtronic, Inc.
12.2.1 Medtronic, Inc. Basic Information
12.2.2 Radiopharmaceuticals in Nuclear Medicine Product Introduction
12.2.3 Medtronic, Inc. Production, Value, Price, Gross Margin 2015-202012.3 Lantheus Medical Imaging
12.3.1 Lantheus Medical Imaging Basic Information
12.3.2 Radiopharmaceuticals in Nuclear Medicine Product Introduction
12.3.3 Lantheus Medical Imaging Production, Value, Price, Gross Margin 2015-202012.4 IBA Group
12.4.1 IBA Group Basic Information
12.4.2 Radiopharmaceuticals in Nuclear Medicine Product Introduction
12.4.3 IBA Group Production, Value, Price, Gross Margin 2015-202012.5 Novartis International AG (Advanced accelerator)
12.5.1 Novartis International AG (Advanced accelerator) Basic Information
12.5.2 Radiopharmaceuticals in Nuclear Medicine Product Introduction
12.5.3 Novartis International AG (Advanced accelerator) Production, Value, Price, Gross Margin 2015-202012.6 Jubilant Life science
12.6.1 Jubilant Life science Basic Information
12.6.2 Radiopharmaceuticals in Nuclear Medicine Product Introduction
12.6.3 Jubilant Life science Production, Value, Price, Gross Margin 2015-2020
12.7 General Electric Co. (healthcare division)
12.7.1 General Electric Co. (healthcare division) Basic Information
12.7.2 Radiopharmaceuticals in Nuclear Medicine Product Introduction
12.7.3 General Electric Co. (healthcare division) Production, Value, Price, Gross Margin 2015-2020
12.8 Fujifilm Holding Corporation
12.8.1 Fujifilm Holding Corporation Basic Information
12.8.2 Radiopharmaceuticals in Nuclear Medicine Product Introduction
12.8.3 Fujifilm Holding Corporation Production, Value, Price, Gross Margin 2015-2020
12.9 Cardinal Health
12.9.1 Cardinal Health Basic Information
12.9.2 Radiopharmaceuticals in Nuclear Medicine Product Introduction
12.9.3 Cardinal Health Production, Value, Price, Gross Margin 2015-202012.10 Curium Pharma
12.10.1 Curium Pharma Basic Information
12.10.2 Radiopharmaceuticals in Nuclear Medicine Product Introduction
12.10.3 Curium Pharma Production, Value, Price, Gross Margin 2015-2020
12.11 Bayer AG
12.11.1 Bayer AG Basic Information
12.11.2 Radiopharmaceuticals in Nuclear Medicine Product Introduction
12.11.3 Bayer AG Production, Value, Price, Gross Margin 2015-2020
12.12 Lantheus Medical Imaging, Inc.
12.12.1 Lantheus Medical Imaging, Inc. Basic Information
12.12.2 Radiopharmaceuticals in Nuclear Medicine Product Introduction
12.12.3 Lantheus Medical Imaging, Inc. Production, Value, Price, Gross Margin 2015-2020
12.13 Mallinckrodt plc
12.13.1 Mallinckrodt plc Basic Information
12.13.2 Radiopharmaceuticals in Nuclear Medicine Product Introduction
12.13.3 Mallinckrodt plc Production, Value, Price, Gross Margin 2015-2020
12.14 Cardinal Health, Inc.
12.14.1 Cardinal Health, Inc. Basic Information
12.14.2 Radiopharmaceuticals in Nuclear Medicine Product Introduction
12.14.3 Cardinal Health, Inc. Production, Value, Price, Gross Margin 2015-2020
13 Industry Outlook13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis13.2 Merger, Acquisition and New Investment
13.3 News of Product Release
14 Global Radiopharmaceuticals in Nuclear Medicine Market Forecast14.1 Global Radiopharmaceuticals in Nuclear Medicine Market Value & Volume Forecast, by Type (2020-2025)
14.1.1 Diagnostic Market Value and Volume Forecast (2020-2025)
14.1.2 Therapeutic Market Value and Volume Forecast (2020-2025)14.2 Global Radiopharmaceuticals in Nuclear Medicine Market Value & Volume Forecast, by Application (2020-2025)
14.2.1 Oncology Market Value and Volume Forecast (2020-2025)
14.2.2 Cardiology Market Value and Volume Forecast (2020-2025)
14.2.3 Neurology Market Value and Volume Forecast (2020-2025)
14.2.4 Thyroid Market Value and Volume Forecast (2020-2025)
14.2.5 Others Market Value and Volume Forecast (2020-2025)14.3 Radiopharmaceuticals in Nuclear Medicine Market Analysis and Forecast by Region
14.3.1 North America Market Value and Consumption Forecast (2020-2025)
14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
14.3.5 South America Market Value and Consumption Forecast (2020-2025)
15 New Project Feasibility Analysis15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter’s Five Forces Analysis
15.1.2 New Entrants SWOT Analysis15.2 Analysis and Suggestions on New Project Investment
List of Tables and Figures
Figure Product Picture of Radiopharmaceuticals in Nuclear Medicine
Table Product Specification of Radiopharmaceuticals in Nuclear Medicine
Table Radiopharmaceuticals in Nuclear Medicine Key Market Segments
Table Key Players Radiopharmaceuticals in Nuclear Medicine Covered
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Size, 2015 – 2025
Table Different Types of Radiopharmaceuticals in Nuclear Medicine
Figure Global Radiopharmaceuticals in Nuclear Medicine Value ($) Segment by Type from 2015-2020
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Share by Types in 2019
Table Different Applications of Radiopharmaceuticals in Nuclear Medicine
Figure Global Radiopharmaceuticals in Nuclear Medicine Value ($) Segment by Applications from 2015-2020
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Share by Applications in 2019
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Share by Regions in 2019
Figure North America Radiopharmaceuticals in Nuclear Medicine Production Value ($) and Growth Rate (2015-2020)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Production Value ($) and Growth Rate (2015-2020)
Figure Asia Pacific Radiopharmaceuticals in Nuclear Medicine Production Value ($) and Growth Rate (2015-2020)
Figure Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Production Value ($) and Growth Rate (2015-2020)
Figure South America Radiopharmaceuticals in Nuclear Medicine Production Value ($) and Growth Rate (2015-2020)
Table Global COVID-19 Status and Economic Overview
Figure Global COVID-19 Status
Figure COVID-19 Comparison of Major Countries
Figure Industry Chain Analysis of Radiopharmaceuticals in Nuclear Medicine
Table Upstream Raw Material Suppliers of Radiopharmaceuticals in Nuclear Medicine with Contact Information
Table Major Players Headquarters, and Service Area of Radiopharmaceuticals in Nuclear Medicine
Figure Major Players Production Value Market Share of Radiopharmaceuticals in Nuclear Medicine in 2019
Table Major Players Radiopharmaceuticals in Nuclear Medicine Product Types in 2019
Figure Production Process of Radiopharmaceuticals in Nuclear Medicine
Figure Manufacturing Cost Structure of Radiopharmaceuticals in Nuclear Medicine
Figure Channel Status of Radiopharmaceuticals in Nuclear Medicine
Table Major Distributors of Radiopharmaceuticals in Nuclear Medicine with Contact Information
Table Major Downstream Buyers of Radiopharmaceuticals in Nuclear Medicine with Contact Information
Table Global Radiopharmaceuticals in Nuclear Medicine Value ($) by Type (2015-2020)
Table Global Radiopharmaceuticals in Nuclear Medicine Value Share by Type (2015-2020)
Figure Global Radiopharmaceuticals in Nuclear Medicine Value Share by Type (2015-2020)
Table Global Radiopharmaceuticals in Nuclear Medicine Production by Type (2015-2020)
Table Global Radiopharmaceuticals in Nuclear Medicine Production Share by Type (2015-2020)
Figure Global Radiopharmaceuticals in Nuclear Medicine Production Share by Type (2015-2020)
Figure Global Radiopharmaceuticals in Nuclear Medicine Value ($) and Growth Rate of Diagnostic (2015-2020)
Figure Global Radiopharmaceuticals in Nuclear Medicine Value ($) and Growth Rate of Therapeutic (2015-2020)
Figure Global Radiopharmaceuticals in Nuclear Medicine Price by Type (2015-2020)
Figure Downstream Market Overview
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption by Application (2015-2020)
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Application (2015-2020)
Figure Global Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Application (2015-2020)
Figure Global Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate of Oncology (2015-2020)
Figure Global Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate of Cardiology (2015-2020)
Figure Global Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate of Neurology (2015-2020)
Figure Global Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate of Thyroid (2015-2020)
Figure Global Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate of Others (2015-2020)
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2015-2020)
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) and Growth (2015-2020)
Table Global Radiopharmaceuticals in Nuclear Medicine Sales by Regions (2015-2020)
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Regions (2015-2020)
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) by Regions (2015-2020)
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Regions (2015-2020)
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Regions in 2015
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Regions in 2019
Figure North America Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2015-2020)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2015-2020)
Figure South America Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure North America COVID-19 Confirmed Cases Major Distribution
Figure North America Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) and Growth (2015-2020)
Table North America Radiopharmaceuticals in Nuclear Medicine Sales by Countries (2015-2020)
Table North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Countries (2015-2020)
Table North America Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) by Countries (2015-2020)
Table North America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries (2015-2020)
Figure United States Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2015-2020)
Figure Canada Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2015-2020)
Figure Mexico Radiopharmaceuticals in Nuclear Medicine Sales and Growth (2015-2020)
Figure Europe COVID-19 Status
Figure Europe COVID-19 Confirmed Cases Major Distribution
Figure Europe Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) and Growth (2015-2020)
Table Europe Radiopharmaceuticals in Nuclear Medicine Sales by Countries (2015-2020)
Table Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Countries (2015-2020)
Table Europe Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) by Countries (2015-2020)
Table Europe Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries (2015-2020)
Figure Germany Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2015-2020)
Figure UK Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2015-2020)
Figure France Radiopharmaceuticals in Nuclear Medicine Sales and Growth (2015-2020)
Figure Italy Radiopharmaceuticals in Nuclear Medicine Sales and Growth (2015-2020)
Figure Spain Radiopharmaceuticals in Nuclear Medicine Sales and Growth (2015-2020)
Figure Russia Radiopharmaceuticals in Nuclear Medicine Sales and Growth (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) and Growth (2015-2020)
Table Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Countries (2015-2020)
Table Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Countries (2015-2020)
Table Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) by Countries (2015-2020)
Table Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries (2015-2020)
Figure China Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2015-2020)
Figure Japan Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2015-2020)
Figure South Korea Radiopharmaceuticals in Nuclear Medicine Sales and Growth (2015-2020)
Figure India Radiopharmaceuticals in Nuclear Medicine Sales and Growth (2015-2020)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales and Growth (2015-2020)
Figure Australia Radiopharmaceuticals in Nuclear Medicine Sales and Growth (2015-2020)
Figure Middle East Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) and Growth (2015-2020)
Table Middle East Radiopharmaceuticals in Nuclear Medicine Sales by Countries (2015-2020)
Table Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Countries (2015-2020)
Table Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) by Countries (2015-2020)
Table Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries (2015-2020)
Figure Saudi Arabia Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2015-2020)
Figure UAE Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2015-2020)
Figure Egypt Radiopharmaceuticals in Nuclear Medicine Sales and Growth (2015-2020)
Figure Nigeria Radiopharmaceuticals in Nuclear Medicine Sales and Growth (2015-2020)
Figure South Africa Radiopharmaceuticals in Nuclear Medicine Sales and Growth (2015-2020)
Figure South America Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) and Growth (2015-2020)
Table South America Radiopharmaceuticals in Nuclear Medicine Sales by Countries (2015-2020)
Table South America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Countries (2015-2020)
Table South America Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) by Countries (2015-2020)
Table South America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries (2015-2020)
Figure Brazil Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2015-2020)
Figure Argentina Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2015-2020)
Figure Columbia Radiopharmaceuticals in Nuclear Medicine Sales and Growth (2015-2020)
Figure Chile Radiopharmaceuticals in Nuclear Medicine Sales and Growth (2015-2020)
Figure Top 3 Market Share of Radiopharmaceuticals in Nuclear Medicine Companies in 2019
Figure Top 6 Market Share of Radiopharmaceuticals in Nuclear Medicine Companies in 2019
Table Major Players Production Value ($) Share (2015-2020)
Table Siemens AG Profile
Table Siemens AG Product Introduction
Figure Siemens AG Production and Growth Rate
Figure Siemens AG Value ($) Market Share 2015-2020
Table Medtronic, Inc. Profile
Table Medtronic, Inc. Product Introduction
Figure Medtronic, Inc. Production and Growth Rate
Figure Medtronic, Inc. Value ($) Market Share 2015-2020
Table Lantheus Medical Imaging Profile
Table Lantheus Medical Imaging Product Introduction
Figure Lantheus Medical Imaging Production and Growth Rate
Figure Lantheus Medical Imaging Value ($) Market Share 2015-2020
Table IBA Group Profile
Table IBA Group Product Introduction
Figure IBA Group Production and Growth Rate
Figure IBA Group Value ($) Market Share 2015-2020
Table Novartis International AG (Advanced accelerator) Profile
Table Novartis International AG (Advanced accelerator) Product Introduction
Figure Novartis International AG (Advanced accelerator) Production and Growth Rate
Figure Novartis International AG (Advanced accelerator) Value ($) Market Share 2015-2020
Table Jubilant Life science Profile
Table Jubilant Life science Product Introduction
Figure Jubilant Life science Production and Growth Rate
Figure Jubilant Life science Value ($) Market Share 2015-2020
Table General Electric Co. (healthcare division) Profile
Table General Electric Co. (healthcare division) Product Introduction
Figure General Electric Co. (healthcare division) Production and Growth Rate
Figure General Electric Co. (healthcare division) Value ($) Market Share 2015-2020
Table Fujifilm Holding Corporation Profile
Table Fujifilm Holding Corporation Product Introduction
Figure Fujifilm Holding Corporation Production and Growth Rate
Figure Fujifilm Holding Corporation Value ($) Market Share 2015-2020
Table Cardinal Health Profile
Table Cardinal Health Product Introduction
Figure Cardinal Health Production and Growth Rate
Figure Cardinal Health Value ($) Market Share 2015-2020
Table Curium Pharma Profile
Table Curium Pharma Product Introduction
Figure Curium Pharma Production and Growth Rate
Figure Curium Pharma Value ($) Market Share 2015-2020
Table Bayer AG Profile
Table Bayer AG Product Introduction
Figure Bayer AG Production and Growth Rate
Figure Bayer AG Value ($) Market Share 2015-2020
Table Lantheus Medical Imaging, Inc. Profile
Table Lantheus Medical Imaging, Inc. Product Introduction
Figure Lantheus Medical Imaging, Inc. Production and Growth Rate
Figure Lantheus Medical Imaging, Inc. Value ($) Market Share 2015-2020
Table Mallinckrodt plc Profile
Table Mallinckrodt plc Product Introduction
Figure Mallinckrodt plc Production and Growth Rate
Figure Mallinckrodt plc Value ($) Market Share 2015-2020
Table Cardinal Health, Inc. Profile
Table Cardinal Health, Inc. Product Introduction
Figure Cardinal Health, Inc. Production and Growth Rate
Figure Cardinal Health, Inc. Value ($) Market Share 2015-2020
Table Market Driving Factors of Radiopharmaceuticals in Nuclear Medicine
Table Merger, Acquisition and New Investment
Table Global Radiopharmaceuticals in Nuclear Medicine Market Value ($) Forecast, by Type
Table Global Radiopharmaceuticals in Nuclear Medicine Market Volume Forecast, by Type
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Value ($) and Growth Rate Forecast of Diagnostic (2020-2025)
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Volume ($) and Growth Rate Forecast of Diagnostic (2020-2025)
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Value ($) and Growth Rate Forecast of Therapeutic (2020-2025)
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Volume ($) and Growth Rate Forecast of Therapeutic (2020-2025)
Table Global Market Value ($) Forecast by Application (2020-2025)
Table Global Market Volume Forecast by Application (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Oncology (2020-2025)
Figure Market Volume and Growth Rate Forecast of Oncology (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Cardiology (2020-2025)
Figure Market Volume and Growth Rate Forecast of Cardiology (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Neurology (2020-2025)
Figure Market Volume and Growth Rate Forecast of Neurology (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Thyroid (2020-2025)
Figure Market Volume and Growth Rate Forecast of Thyroid (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Others (2020-2025)
Figure Market Volume and Growth Rate Forecast of Others (2020-2025)
Figure North America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure North America Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Europe Consumption and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure South America Consumption and Growth Rate Forecast (2020-2025)
Figure Porter’s Five Forces Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery
-
The Global Radiopharmaceuticals in Nuclear Medicine Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
During the projected year from 2025 to 2030, the Global Radiopharmaceuticals in Nuclear Medicine Market is expected to grow at a CAGR of xx%.
As the shift to value addition continues, companies in the Global Radiopharmaceuticals in Nuclear Medicine Market face the dual challenge of improving interoperability to optimize performance and experience.
The latest version of the Global Radiopharmaceuticals in Nuclear Medicine Market study includes a market size breakdown by relevant business segments, applications, and geography, as well as qualitative insights such as Patent Analysis*, Market Entropy, Key Development Activities, Market Dynamics, PEST and PORTER models, and more.
